Annual licence for large closed-network private-payer claims data, one therapeutic area

$100k–300k

USD per therapeutic area per year (annual licence), US

“annual licenses for large, closed network, third‐party, private payer claims data in the United States generally costing $100k–300k per therapeutic area (TA)”

Dagenais et al., Clinical Pharmacology & Therapeutics 2022, Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design, 2021-11

Kind of source
Peer-reviewed study
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
The authors summarise what real-world data typically costs to acquire; it is a range, not a price list. Medicare fee-for-service claims cannot be licensed directly.

Used in

Kept as evidence; no figure on the platform is computed from it yet.